Possible implications of MCAM expression in metastasis and non-metastatic of primary uveal melanoma patients

Current Eye Research

Volumn 34, Issue 11, 2009, Pages 1004-1009

  Beutel, Julia ^a   Wegner, Jürgen ^b   Wegner, Rayime ^b   Ziemssen, Focke ^b   Nassar, Khaled ^a   Rohrbach, Jens Martin ^b   Hilgers, Ralf Dieter ^c   Lüke, Matthias ^a   Grisanti, Salvatore ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

MCAM; Melanoma cell adhesion molecule; Metastasis; Prognostic factors; Uveal melanoma

Indexed keywords

CD146 ANTIGEN; PARAFFIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER INVASION; CANCER STAGING; CELL TYPE; CILIARY BODY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; UVEA MELANOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD146; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; PARAFFIN EMBEDDING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; UVEAL NEOPLASMS;

EID: 72449136322     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713680903262205     Document Type: Article

References (26)

1. Singh AD, Topham A. Survival rates with uveal melanoma in the United States: 1973-1997. Ophthalmology. 2003;110:962-965. (Pubitemid 36560497)
2. Kivela T, Eskelin S, Kujala E. Metastatic uveal melanoma. Int Ophthalmol Clin. 2006;46:133-149.
3. Bardin N, Frances V, Lesaule G, Horschowski N, George F, Sampol J. Identification of the S-Endo 1 endothelialassociated antigen. Biochem Biophys Res Commun. 1996;218:210-216.
4. Pardo M, Garcia A, Thomas B, Pineiro A, Akoulitchev A, Dwek RA, Zitzmann N. The characterization of the invasion phenotype of uveal melanoma tumor cells shows the presence of MUC18 and HMG-1 metastasis markers and leads to the identification of DJ-1 as a potential serum biomarker. Int J Cancer. 2006;119:1014-1022.
5. Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics. 1989;45:255-268.
6. Schmittel A, Bechrakis NE, Martus P, Mutlu D, Scheibenbogen C, Bornfeld N, Foerster MH, Thiel E, Keilholz U. Independent prognostic factors for distant metastases and survival in patients with primary uveal melanoma. Eur J Cancer. 2004;40:2389-2395.
7. Diener-West M, Reynolds SM, Agugliaro DJ, Caldwell R, Cumming K, Earle JD, Hawkins BS, Hayman JA, Jaiyesimi I, Jampol LM, Kirkwood JM, Koh WJ, Robertson DM, Shaw JM, Straatsma BR, Thoma J. Collaborative Ocular Melanoma Study Group. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26. Arch Ophthalmol. 2005;123:1639-1643.
8. Cohen VM, Carter MJ, Kemeny A, Radatz M, Rennie IG. Metastasis-free survival following treatment for uveal melanoma with either stereotactic radiosurgery or enucleation. Acta Ophthalmol Scand. 2003;81:383-388.
9. Isager P, Ehlers N, Overgaard J. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas. Acta Ophthalmol Scand. 2004;82:517-525. (Pubitemid 39386961)
10. Seregard S, Kock E. Prognostic indicators following enucleation for posterior uveal melanoma. A multivariate analysis of long-term survival with minimized loss to follow-up. Acta Ophthalmol Scand. 1995;73:340-344.
11. Coleman K, Baak JP, Van Diest P, Mullaney J, Farrell M, Fenton M. Prognostic factors following enucleation of 111 uveal melanomas. Br J Ophthalmol. 1993;77:688-692.
12. Coleman K, Baak JP, Van Diest PJ, Mullaney J. Prognostic value of morphometric features and the Callender classification in uveal melanomas. Ophthalmology. 1996;103:1634-1641.
13. Kodjikian L, Roy P, Rouberol F, Garweg JG, Chauvel P, Manon L, Jean-Louis B, Little RE, Sasco AJ, Grange JD. Survival after proton-beam irradiation of uveal melanomas. Am J Ophthalmol. 2004;137:1002-1010.
14. Gamel JW, McCurdy JB, McLean IW. A comparison of prognostic covariates for uveal melanoma. Invest Ophthalmol Vis Sci. 1992;33:1919-1922.
15. Seddon JM, Albert DM, Lavin PT, Robinson N. A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol. 1983;101:1894-1899.
16. McLean IW, Foster WD, Zimmerman LE, Gamel JW. Modifications of Callender's classification of uveal melanoma at the Armed Forces Institute of Pathology. Am J Ophthalmol. 1983;96:502-509.
17. Wu GJ, Wu MW, Wang SW, Liu Z, Qu P, Peng Q, Yang H, Varma VA, Sun QC, Petros JA, Lim SD, Amin MB. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression. Gene. 2001;279:17-31.
18. Van Bokhoven A, Varella-Garcia M, Korch C, Miller GJ. TSU-Pr1 and JCA-1 cells are derivatives of T24 bladder carcinoma cells and are not of prostatic origin. Cancer Res. 2001;61:6340-6344.
19. Lehmann JM, Holzmann B, Breitbart EW, Schmiegelow P, Riethmuller G, Johnson JP. Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with a molecular weight of 76,000. Cancer Res. 1987;47:841-845.
20. Holzmann B, Brocker EB, Lehmann JM, Rutter DJ, Sorg C, Riethmuller G, Johnson JP. Tumor progression in human malignant melanoma: Five stages defined by their antigenic phenotypes. Int J Cancer. 1987;39:466-471.
21. Pardo M, Garcia A, Thomas B, Pineiro A, Akoulitchev A, Dwek RA, Zitzmann N. Proteome analysis of a human uveal melanoma primary cell culture by 2-DE and MS. Proteomics. 2005;5:4980-4993.
22. Lai K, Sharma V, Jager MJ, Conway RM, Madigan MC. Expression and distribution of MUC18 in human uveal melanoma. Virchows Arch. 2007;451:967-976.
23. Anastassiou G, Esser M, Bader E, Steuhl KP, Bornfeld N. Expression of cell adhesion molecules and tumour infiltrating leucocytes in conjunctival melanoma. Melanoma Res. 2004;14:381-385.
24. Albelda SM, Oliver PD, Romer LH, Buck CA. EndoCAM: A novel endothelial cell-cell adhesion molecule. J Cell Biol. 1990;110:1227-1237.
25. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell. 1991;64:327-336.
26. Melnikova VO, Bar-Eli M. Bioimmunotherapy for melanoma using fully human antibodies targeting MCAM/MUC18 and IL-8. Pigment Cell Res. 2006;19: 395-405.